Lansoprazole Tablet, Orally Disintegrating, Delayed Release
Product Images NDC 16714-186

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 16714-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
This is a description of a medication package of Lansoprazole in the form of delayed-release orally disintegrating tablets, with a strength of 15mg, manufactured by Norbertaralc Industries. The tablets contain Phenylalanine and the recommended storage temperature is between 58 and 77°F. The package provides contact information for further medical consultation and information.*
FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
This is a description of Lansoprazole - Delayed-Release orally disintegrating tablets. These tablets contain 30 mg of Lansoprazole USP in microgranules. The Phenylalanine content in each tablet is 5.04 mg. The recommended dosage is not available, and it is advised to refer to the package for complete prescribing information. The tablets are stored at a temperature range of 20°C to 25°C. These tablets are produced and distributed by Northstar.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
The text provides a chart representing the mean severity of day heartburn by study day for evaluative patients categorized as severe, moderate, mild, and none. The chart includes data from three groups: a placebo group, a group taking Lansoprazole 15 mg, and a group taking Lansoprazole 30 mg. The chart shows the progression of evaluations over a specific duration of days from the start of the treatment.*
FDA Label Image

Figure2 (Figure2)

FDA Label Image
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.